|
2023 |
Procurement of Gemcitabine |
IB No. 2023-043 |
21,495,286.00 |
25,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 22, 2022 |
|
2023 |
Procurement of Capecitabine |
IB No. 2023-044 |
15,638,436.00 |
25,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 22, 2022 |
|
2023 |
Procurement of Bicalutamide |
IB No. 2023-045 |
1,181,439.00 |
5,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 22, 2022 |
|
2023 |
Procurement of Transfusion Transmissible Infections (TTIs) Reagents with Machine Tie-up |
IB No. 2023-046 |
30,874,311.00 |
25,000.00 |
November 29, 2022, 10:00 am |
December 13, 2022, 9:00 am |
November 21, 2022 |
|
2023 |
Procurement of Pathogen Reduction Kit (Platelet) |
IB No. 2023-047 |
2,750,000.00 |
5,000.00 |
November 29, 2022, 10:00 am |
December 13, 2022, 9:00 am |
November 21, 2022 |
|
2023 |
Procurement of Pathogen Reduction Kit (Platelet)-Re-Bid |
IB No. 2023-047-A |
2,750,000.00 |
5,000.00 |
February 7, 2023, 10:00 am |
February 21, 2023, 9:00 am |
January 30, 2023 |
|
2023 |
Procurement of Hemoglobin Determination Reagent with Machine Tie-Up |
IB No. 2023-048 |
7,063,501.00 |
10,000.00 |
November 29, 2022, 10:00 am |
December 13, 2022, 9:00 am |
November 21, 2022 |
|
2023 |
Procurement of Doxorubicin |
IB No. 2023-049 |
5,084,454.00 |
10,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 29, 2022 |
|
2023 |
Procurement of Filgrastim |
IB No. 2023-050 |
46,818,153.00 |
25,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 29, 2022 |
|
2023 |
Procurement of Etoposide, Fluorouracil, and Bleomycin |
IB No. 2023-051 |
1,423,099.00 |
5,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 29, 2022 |
